{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for benzyl root_notes_note in Note (approximate match)
Status:
US Approved Allergenic Extract
(1972)
Source:
BLA102192
(1972)
Source URL:
First approved in 1972
Source:
BLA102192
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Allergenic Extract
(1972)
Source:
BLA102192
(1972)
Source URL:
First approved in 1968
Source:
BLA101833
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Allergenic Extract
(1967)
Source:
BLA101376
(1967)
Source URL:
First approved in 1967
Source:
BLA101376
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Allergenic Extract
(1967)
Source:
BLA101376
(1967)
Source URL:
First approved in 1967
Source:
BLA101376
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M032
(2010)
Source URL:
First approved in 2010
Source:
M032
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
Status:
Investigational
Source:
INN:taplucainium chloride [INN]
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Designated
Source:
FDA ORPHAN DRUG:884022
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
![Structure of (6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-4,7-dioxo-2-((3-(pyridin-2-yl)isoxazol-5-yl)methyl)-8-(quinolin-5-ylmethyl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide methane sulfonic acid](/img/b7c96efd-21ee-4391-ade7-0aedf964a744.svg?size=200&context=jjzbdufetm)
![Structure of 7-Benzyl-4,7-diazaspiro[2.5]octane dihydrochloride](/img/53b918e1-764d-4337-ae79-32d3adaf421b.svg?size=200&context=jjzbdufetm)